Ignite Creation Date:
2024-05-05 @ 7:27 PM
Last Modification Date:
2024-10-26 @ 9:49 AM
Study NCT ID:
NCT00671242
Status:
COMPLETED
Last Update Posted:
2008-05-05
First Post:
2008-04-30
Brief Title:
Angiogenesis With Positron Emission Tomography PET Tracer Uptake
Sponsor:
Gunma University
Organization:
Gunma University
Study Overview
Official Title:
Correlation of Angiogenesis With 18F-FMT and 18F-FDG Uptake in Non-Small Cell Lung Cancer
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
angiogenesis
Brief Summary:
Purpose L-3-18F-α-methyltyrosine 18F-FMT is an amino-acid tracer for PET We have conducted a clinicopathologic study to elucidate the correlation of angiogenesis with 18F-FMT and 18F-FDG uptake in the patients with non-small cell lung cancer NSCLC
Method Thirty-seven NSCLC patients were enrolled in this study and a pair of PET study with 18F-FMT and 18F-FDG was performed Uptake of PET tracers was evaluated with standardized uptake value VEGF CD31 CD34 LAT1 and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical staining and correlated with the clinicopathologic variables and the uptake of PET tracers
Method Thirty-seven NSCLC patients were enrolled in this study and a pair of PET study with 18F-FMT and 18F-FDG was performed Uptake of PET tracers was evaluated with standardized uptake value VEGF CD31 CD34 LAT1 and Ki-67 labeling index of the resected tumors were analyzed by immunohistochemical staining and correlated with the clinicopathologic variables and the uptake of PET tracers
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None